The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer
Authors
Keywords
-
Journal
ONCOLOGY
Volume 83, Issue 2, Pages 108-116
Publisher
S. Karger AG
Online
2012-07-09
DOI
10.1159/000339542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
- (2017) N. W. Choong et al. JOURNAL OF CLINICAL ONCOLOGY
- Pemetrexed (P) and bevacizumab (B) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC): updated results of a phase II trial
- (2017) T. M. Feinstein et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
- (2011) J. K. Salama et al. ANNALS OF ONCOLOGY
- PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
- (2011) K Dredge et al. BRITISH JOURNAL OF CANCER
- Combined Modality Treatment With Chemotherapy, Radiation Therapy, Bevacizumab, and Erlotinib in Patients With Locally Advanced Squamous Carcinoma of the Head and Neck
- (2011) John D. Hainsworth et al. CANCER JOURNAL
- Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells
- (2011) H. Xu et al. CLINICAL CANCER RESEARCH
- Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro
- (2011) D. Sano et al. CLINICAL CANCER RESEARCH
- Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor–Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2011) Katherine M. Krajewski et al. EUROPEAN UROLOGY
- Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin
- (2011) Jing Liu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot Study
- (2011) Stephanie B. Donaldson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- (2011) Athanassios Argiris et al. JOURNAL OF CLINICAL ONCOLOGY
- Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
- (2011) Jean-Pascal Machiels et al. LANCET ONCOLOGY
- Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab
- (2011) Valérie Jouan-Hureaux et al. MICROVASCULAR RESEARCH
- Sorafenib Enhances the Antitumor Effects of Chemoradiation Treatment by Downregulating ERCC-1 and XRCC-1 DNA Repair Proteins
- (2011) A. Yadav et al. MOLECULAR CANCER THERAPEUTICS
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- The mTOR-targeting drug temsirolimus enhances the growth-inhibiting effects of the cetuximab–bevacizumab–irradiation combination on head and neck cancer xenografts
- (2011) Alexandre Bozec et al. ORAL ONCOLOGY
- Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts
- (2011) Shousong Cao et al. ORAL ONCOLOGY
- Efficient Targeting of Head and Neck Squamous Cell Carcinoma by Systemic Administration of a Dual uPA and MMP-Activated Engineered Anthrax Toxin
- (2011) Jeffrey M. Schafer et al. PLoS One
- Biology of vascular endothelial growth factor and its receptors in head and neck cancer: Beyond angiogenesis
- (2010) Apostolos Christopoulos et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420
- (2010) Stephen K. Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results
- (2010) Nathalie Lassau et al. RADIOLOGY
- Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice
- (2010) Yixiang Wang et al. Targeted Oncology
- Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model
- (2009) A. Bozec et al. ANNALS OF ONCOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
- (2009) George Fountzilas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease
- (2009) Thomas S. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of PTK/ZK on the Angiogenic Switch in Head and Neck Tumors
- (2009) M. Miyazawa et al. JOURNAL OF DENTAL RESEARCH
- Targeting the future in head and neck cancer
- (2009) David M Brizel LANCET ONCOLOGY
- Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
- (2009) Ezra EW Cohen et al. LANCET ONCOLOGY
- Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model
- (2008) A Bozec et al. BRITISH JOURNAL OF CANCER
- Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer
- (2008) Tanguy Y. Seiwert et al. JOURNAL OF CLINICAL ONCOLOGY
- Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications
- (2008) Rifat Hasina et al. LABORATORY INVESTIGATION
- Targeting Angiogenesis in Head and Neck Cancer
- (2008) Tanguy Y. Seiwert et al. SEMINARS IN ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started